Consistent with this dual role, mesenchymal stem cells have been shown to alleviate TNF-α- and LPS-induced apoptosis by activating the CXCL12/CXCR4 axis, thereby reducing lung injury and fibrosis in experimental acute respiratory distress syndrome (ARDS) models [22]. This evidence concerns the gene CXCL12 and acute respiratory distress syndrome.